This is an unprecedented time. It is the dedication of healthcare workers that will lead us through this crisis. Thank you for everything you do.

      Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    TIMI Risk Score for STEMI

    Estimates mortality in patients with STEMI.
    When to Use
    Pearls/Pitfalls
    Why Use

    A patient with an ST-Elevation Myocardial Infarction (STEMI) who is post-cath may have bleeding risks and the primary team would like to help objectify risk-benefit of post-PCI medications.

    • Obviously patients with STEMI are already at high risk for complications and adverse outcomes, including death.
    • The TIMI Risk Score for STEMI may help a cardiology, medical and/or intensive care team with weighing risk/benefit of medications (like anticoagulation) and invasive procedures by knowing a patient’s baseline risk.
    • This score was developed based on thrombolytic outcomes, which likely have worse outcomes when compared to PCI.
    • Should be used in patients with diagnosed STEMI, NOT to evaluate patients with chest pain.

    Studies on clinician gestalt estimating mortality and complication risk often underestimate risk, and guidelines recommend higher risk patients receiving more aggressive medical interventions.

    < 65 years
    0
    65-74
    +2
    ≥ 75
    +3
    No
    0
    Yes
    +1
    No
    0
    Yes
    +3
    No
    0
    Yes
    +2
    No
    0
    Yes
    +2
    No
    0
    Yes
    +1
    No
    0
    Yes
    +1
    No
    0
    Yes
    +1

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights
    Dr. David A. Morrow

    About the Creator

    David A. Morrow, MD, MPH, is an associate professor at Harvard Medical School and the director of the Samuel A. Levine Cardiac Unit at Brigham and Women's Hospital in Massachusetts. He is a senior investigator in the TIMI Study Group with a research focus in the management of unstable and stable coronary artery disease, and he directs the TIMI Biomarker Program. Dr. Morrow has more than 150 publications in areas such as risk stratification in patients with ischemic heart disease.

    To view Dr. David A. Morrow's publications, visit PubMed

    Are you Dr. David A. Morrow? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
    MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
    Content Contributors
    About the Creator
    Dr. David A. Morrow
    Are you Dr. David A. Morrow?
    Content Contributors